Targeting RAS -mutant Cancers: Is ERK the Key?
Year: 2015
Type: review
Source: Trends in cancer
Language: English
Subfield: Molecular Biology
Domain: Life Sciences
Open Access status: green
Awards: Washington University Institute of Clinical and Translational Sciences, Mechanisms of PAK1 activation, signaling and tumor resistance, Defining the role of ERK1 and ERK2 in Pancreatic Cancer, Biological Activity of Ras Oncogenes, ERK inhibitor resistance and ERK isoform-dependent growth in pancreatic cancer, Washington University Institute of Clinical and Translational Sciences, Identification of synthetic lethal interactors in pancreatic cancer, Cancer Cell Biology Training Program
OpenAlex ID: W2178192018
